Probiotics are microorganisms primarily bacteria or yeast which when ingested helps to boost immunity in the host these micro florals colonize in the colon and defend the host from harmful bacteria. It reduces dental caries, manages periodontitis, and prevents oral candida infections. These probiotics supplements also help in rising the Lactobacilli count in women and prevent them from diseases such as yeast infection, urinary tract infection, and bacterial vaginosis.
The Global Probiotics Market was valued at $ 43.13bn in 2018 and is forecasted to grow at a promising 6.75% CAGR between 2018 and 2026, resulting in 2026 global sales of $72.74 bn. Market-driven by rising in popularity of probiotic dietary supplements and increasing health consciousness among consumers are some of the components boosting the market. However, international quality standards and regulations for probiotic products and high r&d costs for developing new probiotic strains are some of the components hindering the market. Moreover, expanding consumer awareness about value-added products and probiotics can replace pharmaceutical agents that will provide ample opportunities to the market.
Probiotics Market depending on the ingredient, bacteria segment is dominated due more and more popular during the last two decades as a result of the continuously expanding scientific evidence pointing to their beneficial effects on human health and preventing the growth of pathogenic bacteria, B vitamin synthesis and aiding in digestion. The main benefit of incorporating scientifically-derived bacterial strains in probiotic foods is the balance in the host’s intestinal microbiota and the subsequent enhancement of the immune system.
The Global Probiotics Market is segmented based on products, ingredients, distribution channels, functions, end-users, and regions.
Based on the Products: Probiotic Dietary Supplements and Probiotic Food & Beverages.
Based on the Ingredients: Bacteria and Yeast.
Based on the Distribution Channels: Hypermarkets/Supermarkets, Pharmacies/Drugstores, Specialty Stores and Online Sales.
Based on the Functions: Regular Use, Preventive Healthcare, and Therapeutics.
Based on the End-users: Human Probiotics and Animal Probiotics.
Based on Regions: North America, Asia-Pacific, Europe, and LAMEA. Among that Asia Pacific region is projected to witness high growth during the forecast period due to the demand for improving personal health, adoption of proper diet and opportunities for animal probiotic products, as governments are becoming increasingly concerned about the health and productivity of farm animals. Moreover, huge consumer demand for probiotic applications is to be expanding every quickly in exponential performance of probiotics in the mature markets of China and Japan and countries like China and India are providing ample opportunities to attract the industry sponsors to invest more for the growth of the region.
The key players of the Global Probiotics Market include Arla Foods, Inc, BioGaia AB, Danone, Danisco A/S, Nestle S.A, Yakult Honsha Co., Ltd, Sanofi-Aventis, etc.
Report Description: The report covers an in-depth analysis of the Global Probiotics Market. The report assesses the market products pipeline by-product (Probiotic Dietary Supplements and Probiotic Food & Beverages), by ingredient (Bacteria and Yeast), by distribution channel (Hypermarkets/Supermarkets, Pharmacies/Drugstores, Specialty Stores and Online Sales) by function (Regular Use, Preventive Healthcare and Therapeutics) by end-user (Human Probiotics and Animal Probiotics). In addition, the report includes key insights on other development activities, including (but not limited to) – licensing (In and Out), collaborations, acquisitions, reimbursement, patent, and regulatory designations.
The report includes in-depth company profiles of key players in the Global Probiotics Market. The company profile includes key information on the overview, financial highlights, product portfolio, business strategies, and key recent developments.
The report highlights information on emerging companies with potentially disruptive technologies and new market entrants.
Data Collation (Primary & Secondary)
In-house Estimation (Based on proprietary databases and Models)
Market-related information is assembled from both primary and secondary sources.
Primary sources involved participants from all global stakeholders such as experts from several related industries and suppliers that have been interviewed to obtain and verify critical information as well as to assess prospects of the market. The participants included are CXOs, VPs, and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications annual reports press releases along with paid sources such as Factiva, OneSource, Bloomberg among others.
Top-down and bottom-up approaches: The overall market size was used in the top-down approach to estimate the sizes of other individual submarkets (mentioned in the market segmentation by product, type of manufacturing, and disease) through percentage splits from secondary and primary research. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained.